மும்பை அடிப்படையிலானது ஹாஃப்கைன் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மும்பை அடிப்படையிலானது ஹாஃப்கைன் நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மும்பை அடிப்படையிலானது ஹாஃப்கைன் நிறுவனம் Today - Breaking & Trending Today

Apple announces first-ever $200 million carbon removal initiative : Bulletin: Business Today


Loading the player.
Apple announces first-ever $200 million carbon removal initiative
Cupertino giant Apple on Thursday, April 15, announced a first-of-its-kind carbon removal initiative called Restore Fund . Under this new initiative investments will be made in forestry projects to remove carbon from the atmosphere. The new initiative is part of Apple s broader goal of becoming carbon neutral across its entire value chain by 2
COVID-19 vaccine: Centre permits Mumbai s Haffkine Institute to produce Covaxin
The Centre has given its nod to Mumbai-based Haffkine Institute to manufacture Bharat Biotech s COVID-19 vaccine Covaxin. Technology transfer will take place from Bharat Biotech to Haffkine for manufacturing Covaxin. Haffkine has been given a time of 1 year for it ....

Mumbai Haffkine Institute , Billionaire Mukesh Reliance Industries Ltd , Haffkine Institute , Mumbai Based Haffkine Institute , Bharat Biotech , Arvind Kejriwal Led Delhi , Mukesh Ambani , Mukesh Ambani Led Reliance Industries Ltd , மும்பை ஹாஃப்கைன் நிறுவனம் , கோடீஸ்வரர் முகேஷ் நம்பகத்தன்மை தொழில்கள் லிமிடெட் , ஹாஃப்கைன் நிறுவனம் , மும்பை அடிப்படையிலானது ஹாஃப்கைன் நிறுவனம் , பாரத் பயோடெக் , அரவிந்த் கேஜ்றிவாள் வழிநடத்தியது டெல்ஹி , முகேஷ் அம்பானி , முகேஷ் அம்பானி வழிநடத்தியது நம்பகத்தன்மை தொழில்கள் லிமிடெட் ,

Mumbai-Based Haffkine Gets Centre's Nod To Produce Covaxin


Mumbai-Based Haffkine Gets Centre s Nod To Produce Covaxin
Maharashtra Chief Minister Uddhav Thackeray had earlier requested the Centre to allow the Haffkine Institute to produce Covaxin.
Outlook Web Bureau
2021-04-16T08:07:40+05:30
Mumbai-Based Haffkine Gets Centre s Nod To Produce Covaxin
outlookindia.com
2021-04-16T09:21:52+05:30
Also read
The centre has given its permission to the Mumbai-based Haffkine Institute to manufacture Covaxin, an anti-coronavirus vaccine of Bharat Biotech, an official said on Thursday.
Maharashtra Chief Minister Uddhav Thackeray had earlier requested the Centre to allow the Haffkine Institute to produce Covaxin, which is currently produced by the Hyderabad-based Bharat Biotech, the official from the chief minister s office (CMO) said. ....

Sitaram Kunte , Uddhav Thackeray , Renu Swarup , Technology Department , Union Science , Haffkine Corporation Limited For Covaxin , Haffkine Institute , Mumbai Based Haffkine Institute , Bharat Biotech , Chief Minister Uddhav Thackeray , Hyderabad Based Bharat Biotech , Haffkine Bio Pharmaceutical Corporation Limited , Affkine Covaxin , Accine Haffkine , Ovid Vaccine Mumbai , Covid 19 , Mumbai Covid , Ddhav Thackeray Haffkine , Covaxin Vaccine , சித்தாரம் குண்டே , உத்தவ் தாக்கரே , ரேணு சுவருப் , தொழில்நுட்பம் துறை , தொழிற்சங்கம் அறிவியல் , ஹாஃப்கைன் நிறுவனம் , மும்பை அடிப்படையிலானது ஹாஃப்கைன் நிறுவனம் ,

Centre rushes to raise Covaxin production as second Covid wave hits India hard


Express News Service
NEW DELHI: The Centre has now rushed to handhold Hyderabad-based Bharat Biotech in boosting the production of Covaxin, the country’s first and only indigenous Covid vaccine approved by the drug regulator, as a ferocious second wave of the pandemic has hit India hard.
After allowing Mumbai-based Haffkine Institute to produce Covaxin on a technology transfer basis following a plea by the Maharashtra government, the Union government has also decided to provide Rs 65 crore support to Bharat Biotech’s Bengaluru facility, said government sources.
Covaxin, apart from Covishield by the Serum Institute of India (SII), is the only available Covid vaccine in the country but its share has been fairly limited, only about 15% of about 11.75 crore doses administered, owing to its limited supply.  ....

Andhra Pradesh , United Kingdom , Sumi Sukanya Dutta , Adar Poonawalla , European Union , News Service , Serum Institute Of India , Indian Immunologicals Ltd Hyderabad , Haffkine Institute , Hyderabad Based Bharat Biotech , Mumbai Based Haffkine Institute , Bharat Biotech , Serum Institute , Indian Immunologicals Ltd , Covid Vaccine , Bharat Biotech , India Covid Cases , Covid Vaccination , ஆந்திரா பிரதேஷ் , ஒன்றுபட்டது கிஂக்டம் , சுமி சுகன்யா தத்தா , அடார் பூனாவல்ல , ஐரோப்பிய தொழிற்சங்கம் , செய்தி சேவை , சீரம் நிறுவனம் ஆஃப் இந்தியா , ஹாஃப்கைன் நிறுவனம் ,